{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:52:38Z","timestamp":1793073158141,"version":"4.5.0"},"reference-count":477,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1124,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1469-0691.2011.03602.x","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T21:41:52Z","timestamp":1317159712000},"page":"1-24","source":"Crossref","is-referenced-by-count":236,"special_numbering":"S6","title":["Guidelines for the management of adult lower respiratory tract infections - Summary"],"prefix":"10.1016","volume":"17","author":[{"given":"M.","family":"Woodhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Huchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ortqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schaberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.M.","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03602.x_bib1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"26","author":"Woodhead","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital\u2010acquired, ventilator\u2010associated, and healthcare\u2010associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib3","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","article-title":"Epidemiology and outcomes of health\u2010care\u2010associated pneumonia: results from a large US database of culture\u2010positive pneumonia","volume":"128","author":"Kollef","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib4","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care\u2010associated pneumonia and community\u2010acquired pneumonia: a single\u2010center experience","volume":"51","author":"Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1086\/422317","article-title":"Indicators of potentially drug\u2010resistant bacteria in severe nursing home\u2010acquired pneumonia","volume":"39","author":"El Solh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1164\/rccm.200212-1543OC","article-title":"Microbiology of severe aspiration pneumonia in institutionalized elderly","volume":"167","author":"El\u2010Solh","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archinte.167.13.1393","article-title":"Health care\u2010associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes","volume":"167","author":"Carratala","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib8","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/jama.1978.03290200047020","article-title":"Differences in etiology of pneumonias in nursing home and community patients","volume":"240","author":"Garb","year":"1978","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1183\/09031936.01.00204401","article-title":"A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia","volume":"18","author":"Lim","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1532-5415.1997.tb00977.x","article-title":"A comparison of nursing home\u2010acquired pneumonia patients with patients with community\u2010acquired pneumonia and nursing home patients without pneumonia","volume":"45","author":"Marrie","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.117.5.1378","article-title":"Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community\u2010acquired or nursing home\u2010acquired pneumonia","volume":"117","author":"Meehan","year":"2000","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1532-5415.2001.49203.x","article-title":"Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home\u2010acquired pneumonia","volume":"49","author":"Naughton","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.08-1357","article-title":"Health\u2010care\u2010associated pneumonia among hospitalized patients in a Japanese community hospital","volume":"135","author":"Shindo","year":"2009","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.168.20.2205","article-title":"Prediction of infection due to antibiotic\u2010resistant bacteria by select risk factors for health care\u2010associated pneumonia","volume":"168","author":"Shorr","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-150-1-200901060-00005","article-title":"Outcomes of patients hospitalized with community\u2010acquired, health care\u2010associated, and hospital\u2010acquired pneumonia","volume":"150","author":"Venditti","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2007\/136796","article-title":"Health care\u2010associatedStaphylococcus aureus pneumonia","volume":"18","author":"Webster","year":"2007","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1378\/chest.08-0842","article-title":"Antimicrobial therapy escalation and hospital mortality among patients with health\u2010care\u2010associated pneumonia: a single\u2010center experience","volume":"134","author":"Zilberberg","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/648678","article-title":"Etiology of community\u2010acquired pneumonia: increased microbiological yield with new diagnostic methods","volume":"50","author":"Johansson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1183\/09031936.02.01942001","article-title":"Factors associated with unknown aetiology in patients with community\u2010acquired pneumonia","volume":"20","author":"Ewig","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1034\/j.1600-0463.2002.11007801.x","article-title":"Mixed microbial aetiology of community\u2010acquired pneumonia in children","volume":"110","author":"Korppi","year":"2002","journal-title":"APMIS"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-005-1346-2","article-title":"Community\u2010acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome","volume":"24","author":"Gutierrez","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1378\/chest.125.4.1343","article-title":"Viral community\u2010acquired pneumonia in nonimmunocompromised adults","volume":"125","author":"de","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/135965350601100306","article-title":"The role of viruses in the aetiology of community\u2010acquired pneumonia in adults","volume":"11","author":"Angeles","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmed.2005.02.026","article-title":"Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan","volume":"99","author":"Lauderdale","year":"2005","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1378\/chest.123.5.1512","article-title":"Community\u2010acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients","volume":"123","author":"Wattanathum","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10156-005-0425-8","article-title":"Prospective multicenter study of the causative organisms of community\u2010acquired pneumonia in adults in Japan","volume":"12","author":"Saito","year":"2006","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/thx.2006.075077","article-title":"Incidence and characteristics of viral community\u2010acquired pneumonia in adults","volume":"63","author":"Jennings","year":"2008","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2007.09.014","article-title":"Epidemiology and clinical outcomes of community\u2010acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens","volume":"31","author":"Song","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.06.00058605","article-title":"Mixed community\u2010acquired pneumonia in hospitalised patients","volume":"27","author":"de","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib30","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) \u2010 United States, May\u2013August 2009","volume":"58","author":"Centers for Disease Control (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1034\/j.1399-3003.2000.15d21.x","article-title":"Epidemiology of community\u2010acquired pneumonia in adults: a population\u2010based study","volume":"15","author":"Almirall","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0149-2918(98)80071-4","article-title":"Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group","volume":"20","author":"Anzueto","year":"1998","journal-title":"Clin Ther"},{"issue":"Suppl 4","key":"10.1111\/j.1469-0691.2011.03602.x_bib33","first-page":"115","article-title":"Emerging pathogens of community\u2010acquired pneumonia: a two\u2010year prospective study","volume":"7","author":"Blasi","year":"1995","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/thx.50.5.543","article-title":"Aetiology of community\u2010acquired pneumonia: a prospective study among adults requiring admission to hospital","volume":"50","author":"Bohte","year":"1995","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1525-1497.2000.04429.x","article-title":"Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia","volume":"15","author":"Brandenburg","year":"2000","journal-title":"J Gen Intern Med"},{"issue":"3 Pt 1","key":"10.1111\/j.1469-0691.2011.03602.x_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/ajrccm.163.3.2005075","article-title":"Etiology of severe pneumonia in the very elderly","volume":"163","author":"El Solh","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1179\/joc.1997.9.4.285","article-title":"Etiology and therapy of community\u2010acquired pneumonia","volume":"9","author":"Ginesu","year":"1997","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/BF01709363","article-title":"Prospective study of epidemiology and prognostic factors in community\u2010acquired pneumonia","volume":"15","author":"Gomez","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib39","first-page":"161","article-title":"Severe community acquired pneumonia: a one\u2010year analysis in a tertiary referral intensive care unit","volume":"113","author":"Gowardman","year":"2000","journal-title":"N Z Med J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00365549709011836","article-title":"Recurrence of pneumonia in middle\u2010aged and elderly adults after hospital\u2010treated pneumonia: aetiology and predisposing conditions","volume":"29","author":"Hedlund","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/thx.52.1.17","article-title":"Impact of management guidelines on the outcome of severe community acquired pneumonia","volume":"52","author":"Hirani","year":"1997","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/319746","article-title":"Microbial etiology of community\u2010acquired pneumonia in the adult population of 4 municipalities in eastern Finland","volume":"32","author":"Jokinen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(00)00115-2","article-title":"Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)","volume":"37","author":"Jones","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib44","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1164\/ajrccm.156.6.9702069","article-title":"Community\u2010acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data","volume":"156","author":"Leroy","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1532-5415.1999.tb02567.x","article-title":"Community\u2010acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people","volume":"47","author":"Leroy","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib46","first-page":"11","article-title":"Community\u2010acquired pneumonia in adults: a multicentric observational AIPO study","volume":"54","author":"Logroscino","year":"1999","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/thorax.55.2.133","article-title":"Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study","volume":"55","author":"Lorente","year":"2000","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/thorax.56.4.296","article-title":"Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines","volume":"56","author":"Lim","year":"2001","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0002-9343(96)00255-0","article-title":"Ambulatory patients with community\u2010acquired pneumonia: the frequency of atypical agents and clinical course","volume":"101","author":"Marrie","year":"1996","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib50","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1023\/A:1010912012932","article-title":"Low prevalence ofChlamydia pneumoniae andMycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices","volume":"16","author":"Meijer","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib51","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1164\/ajrccm.159.6.9807070","article-title":"Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community\u2010acquired pneumonia","volume":"159","author":"Menendez","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib52","first-page":"341","article-title":"Community\u2010acquired pneumonia: is there difference in etiology between hospitalized and out\u2010patients?","volume":"86","author":"Michetti","year":"1995","journal-title":"Minerva Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib53","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/BF01709541","article-title":"A predictive model for the treatment approach to community\u2010acquired pneumonia in patients needing ICU admission","volume":"22","author":"Olaechea","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","article-title":"Etiology of community\u2010acquired pneumonia: impact of age, comorbidity, and severity","volume":"160","author":"Ruiz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s100960050400","article-title":"Microbial aetiology of community\u2010acquired pneumonia in hospitalised patients","volume":"18","author":"Socan","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib56","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s100960050419","article-title":"Prospective study of community\u2010acquired pneumonia of bacterial etiology in adults","volume":"18","author":"Sopena","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib57","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/clinids\/22.6.958","article-title":"Chlamydia pneumoniae as a cause of community\u2010acquired pneumonia in hospitalized patients in Berlin","volume":"22","author":"Steinhoff","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1469-0691.2009.02918.x","article-title":"Aetiology of, and risk factors for, recurrent community\u2010acquired pneumonia","volume":"15","author":"Garcia\u2010Vidal","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1469-0691.2005.01150.x","article-title":"Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin\u2010resistantStaphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton\u2010Valentine leukocidin genes","volume":"11","author":"Berglund","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","article-title":"Association betweenStaphylococcus aureus strains carrying gene for Panton\u2010Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients","volume":"359","author":"Gillet","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib61","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3201\/eid1206.051141","article-title":"Severe community\u2010acquired pneumonia due toStaphylococcus aureus, 2003\u201304 influenza season","volume":"12","author":"Hageman","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib62","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of Panton\u2010Valentine leukocidin\u2010producingStaphylococcus aureus in primary skin infections and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib63","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JCM.02311-06","article-title":"Epidemiology and outcomes of community\u2010associated methicillin\u2010resistantStaphylococcus aureus infection","volume":"45","author":"Davis","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/thx.2004.027441","article-title":"Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care","volume":"61","author":"Creer","year":"2006","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10096-003-1042-z","article-title":"Viral lower respiratory tract infection in the elderly: a prospective in\u2010hospital study","volume":"22","author":"Flamaing","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib66","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1378\/chest.08-0888","article-title":"Viral infection in adults hospitalized with community\u2010acquired pneumonia: prevalence, pathogens, and presentation","volume":"134","author":"Johnstone","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib67","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","article-title":"Avian influenza A (H5N1) infection in humans","volume":"353","author":"Beigel","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid1102.041061","article-title":"Human disease from influenza A (H5N1), Thailand, 2004","volume":"11","author":"Chotpitayasunondh","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rcc.2004.10.003","article-title":"Community\u2010acquired pneumonia: new facets of an old disease \u2013 Hantavirus pulmonary syndrome","volume":"11","author":"Miedzinski","year":"2005","journal-title":"Respir Care Clin N Am"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1155\/2006\/152612","article-title":"An outbreak of human Coronavirus OC43 infection and serological cross\u2010reactivity with SARS Coronavirus","volume":"17","author":"Patrick","year":"2006","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib71","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib72","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMoa0904023","article-title":"Severe respiratory disease concurrent with the circulation of H1N1 influenza","volume":"361","author":"Chowell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jinf.2005.11.006","article-title":"The influence of age and gender on the population\u2010based incidence of community\u2010acquired pneumonia caused by different microbial pathogens","volume":"53","author":"Gutierrez","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib74","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1017\/S0950268807007844","article-title":"The bacteriology of pneumonia diagnosed in Western Australian emergency departments","volume":"135","author":"Ingarfield","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib75","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1378\/chest.113.6.1542","article-title":"Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function","volume":"113","author":"Eller","year":"1998","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1378\/chest.116.1.40","article-title":"Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD","volume":"116","author":"Miravitlles","year":"1999","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1843.2006.01002.x","article-title":"Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2\u2010year prospective study","volume":"12","author":"Alamoudi","year":"2007","journal-title":"Respirology"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib78","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.rmed.2008.06.006","article-title":"Respiratory viral infection in exacerbations of COPD","volume":"102","author":"McManus","year":"2008","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000093158","article-title":"Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum","volume":"74","author":"Roche","year":"2007","journal-title":"Respiration"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib80","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.rmed.2007.07.015","article-title":"A community\u2010based, time\u2010matched, case\u2010control study of respiratory viruses and exacerbations of COPD","volume":"101","author":"Hutchinson","year":"2007","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib81","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00012707","article-title":"The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease","volume":"30","author":"Diederen","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1378\/chest.06-1355","article-title":"A 1\u2010year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD","volume":"131","author":"Ko","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1017\/S0950268803008872","article-title":"Bacterial infection in exacerbated COPD with changes in sputum characteristics","volume":"131","author":"Monso","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib85","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1378\/chest.122.4.1264","article-title":"Pneumonic vs nonpneumonic acute exacerbations of COPD","volume":"122","author":"Lieberman","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib86","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/137.4.377","article-title":"Infections with viruses andMycoplasma pneumoniae during exacerbations of chronic bronchitis","volume":"137","author":"Buscho","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thorax.57.1.15","article-title":"Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors","volume":"57","author":"Angrill","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib89","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1378\/chest.114.6.1594","article-title":"The effect ofPseudomonas aeruginosa infection on clinical parameters in steady\u2010state bronchiectasis","volume":"114","author":"Ho","year":"1998","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib90","first-page":"1","article-title":"Q fever in the Netherlands: an update on the epidemiology and control measures","volume":"15","author":"van der","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib91","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/254516a0","article-title":"Penicillin\u2010binding proteins and cell shape inE.\u00a0coli","volume":"254","author":"Spratt","year":"1975","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib92","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.43.6.1480","article-title":"Emergence in france of multiple clones of clinicalStreptococcus pneumoniae isolates with high\u2010level resistance to amoxicillin","volume":"43","author":"Doit","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib93","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/clinids\/24.2.148","article-title":"Treatment of penicillin\u2010resistant pneumococcal bacteremia in neutropenic patients with cancer","volume":"24","author":"Carratala","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib94","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1469-0691.2008.02651.x","article-title":"Prevalence of penicillin and erythromycin resistance among invasiveStreptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region","volume":"15","author":"Borg","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib96","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergentStreptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib97","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dkp210","article-title":"Emergence of a multidrug\u2010resistant clone (ST320) among invasive serotype 19A pneumococci in Spain","volume":"64","author":"Ardanuy","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib98","series-title":"Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100\u2010S18","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib99","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/497594","article-title":"Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?","volume":"42","author":"Peterson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijantimicag.2004.10.007","article-title":"Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin\/clavulanate (2000\/125 mg) in adults with community\u2010acquired pneumonia caused byStreptococcus pneumoniae, including penicillin\u2010resistant strains","volume":"25","author":"File","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib102","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.45.1.342-344.2001","article-title":"Identification of an erm(A) erythromycin resistance methylase gene inStreptococcus pneumoniae isolated in Greece","volume":"45","author":"Syrogiannopoulos","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib103","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates ofStreptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib104","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/AAC.47.6.1777-1783.2003","article-title":"Macrolide resistance by ribosomal mutation in clinical isolates ofStreptococcus pneumoniae from the PROTEKT 1999\u20132000 study","volume":"47","author":"Farrell","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin\u2010resistantStreptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib106","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib107","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.mcna.2006.07.010","article-title":"Macrolide and ketolide resistance withStreptococcus pneumoniae","volume":"90","author":"Doern","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib108","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkm338","article-title":"Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin byStreptococcus pneumoniae in vitro","volume":"60","author":"Anderson","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib109","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets inStreptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","article-title":"Mutant prevention concentrations of fluoroquinolones for clinical isolates ofStreptococcus pneumoniae","volume":"45","author":"Blondeau","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib111","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3201\/eid1506.080684","article-title":"Changes in fluoroquinolone\u2010resistantStreptococcus pneumoniae after 7\u2010valent conjugate vaccination, Spain","volume":"15","author":"de la Campa","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1111\/j.1469-0691.2011.03602.x_bib112","first-page":"ii87","article-title":"Non\u2010susceptibility trends and serotype distributions amongStreptococcus pneumoniae from community\u2010acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007","volume":"62","author":"Farrell","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib113","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/dkl310","article-title":"Longitudinal European surveillance study of antibiotic resistance ofHaemophilus influenzae","volume":"58","author":"Jansen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib114","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/AAC.47.3.1017-1022.2003","article-title":"Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility ofHaemophilus influenzae clinical isolates","volume":"47","author":"Peric","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1111\/j.1469-0691.2011.03602.x_bib115","first-page":"ii97","article-title":"Non\u2010susceptibility trends amongHaemophilus influenzae and Moraxella catarrhalis from community\u2010acquired respiratory tract infections in the UK and Ireland, 1999\u20132007","volume":"62","author":"Morrissey","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib116","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000160183","article-title":"Antimicrobial susceptibilities of 930Haemophilus influenzae clinical strains isolated from the island of Crete, Greece","volume":"54","author":"Kofteridis","year":"2008","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib117","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/AAC.00971-07","article-title":"National and regional assessment of antimicrobial resistance among community\u2010acquired respiratory tract pathogens identified in a 2005\u20132006 U.S. Faropenem surveillance study","volume":"51","author":"Critchley","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib118","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/AAC.47.1.161-165.2003","article-title":"In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS\u2010284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"47","author":"Waites","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib119","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/AAC.47.1.39-42.2003","article-title":"In vitro activities of ABT\u2010773 and other antimicrobials against human mycoplasmas","volume":"47","author":"Waites","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib121","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","article-title":"Characterization and molecular analysis of macrolide\u2010resistantMycoplasma pneumoniae clinical isolates obtained in Japan","volume":"48","author":"Matsuoka","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib122","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.49.6.2302-2306.2005","article-title":"Emergence of macrolide\u2010resistantMycoplasma pneumoniae with a 23S rRNA gene mutation","volume":"49","author":"Morozumi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib123","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/AAC.00779-07","article-title":"Increased macrolide resistance ofMycoplasma pneumoniae in pediatric patients with community\u2010acquired pneumonia","volume":"52","author":"Morozumi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib124","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","article-title":"Occurrence of macrolide\u2010resistantMycoplasma pneumoniae strains in Germany","volume":"16","author":"Dumke","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dkp160","article-title":"Increased macrolide resistance ofMycoplasma pneumoniae in France directly detected in clinical specimens by real\u2010time PCR and melting curve analysis","volume":"64","author":"Peuchant","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.130.2.623-a","article-title":"Staphylococcus aureus in community\u2010acquired pneumonia","volume":"130","author":"Stralin","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib127","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib128","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/jac\/dkn096","article-title":"Guidelines for UK practice for the diagnosis and management of methicillin\u2010resistantStaphylococcus aureus (MRSA) infections presenting in the community","volume":"61","author":"Nathwani","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib129","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/383320","article-title":"Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia","volume":"189","author":"Drusano","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib130","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.49.12.5107-5111.2005","article-title":"In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery","volume":"49","author":"Hutschala","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib131","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2007.05.023","article-title":"Intrapulmonary pharmacodynamics of high\u2010dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease","volume":"30","author":"Conte","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.diagmicrobio.2008.04.008","article-title":"Pharmacokinetics\u2010pharmacodynamics of quinolones againstStreptococcus pneumoniae in patients with community\u2010acquired pneumonia","volume":"62","author":"Bhavnani","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib133","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2459\/01.JCM.0000228690.40452.d3","article-title":"Early diagnosis of congestive heart failure: clinical utility of B\u2010type natriuretic peptide testing associated with Doppler echocardiography","volume":"7","author":"Aspromonte","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijcard.2005.08.003","article-title":"Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure","volume":"110","author":"Mikkelsen","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib135","first-page":"327","article-title":"The diagnostic accuracy and utility of a B\u2010type natriuretic peptide test in a community population of patients with suspected heart failure","volume":"56","author":"Fuat","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib136","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bmj.324.7350.1370","article-title":"Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study","volume":"324","author":"Van Schayck","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib137","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/fampra\/cmp026","article-title":"The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review","volume":"26","author":"Broekhuizen","year":"2009","journal-title":"Fam Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib138","first-page":"358","article-title":"Contributions of symptoms, signs, erythrocyte sedimentation rate, and C\u2010reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection","volume":"53","author":"Hopstaken","year":"2003","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib139","first-page":"465","article-title":"Can history and exam alone reliably predict pneumonia?","volume":"56","author":"Graffelman","year":"2007","journal-title":"J Fam Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.11.023","article-title":"Performance of a bedside C\u2010reactive protein test in the diagnosis of community\u2010acquired pneumonia in adults with acute cough","volume":"116","author":"Flanders","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib141","first-page":"555","article-title":"Procalcitonin versus C\u2010reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care","volume":"57","author":"Holm","year":"2007","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib142","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bmj.38483.478183.EB","article-title":"Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review","volume":"331","author":"van der","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib143","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/fampra\/cmn095","article-title":"C\u2010reactive protein and community\u2010acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies","volume":"26","author":"Falk","year":"2009","journal-title":"Fam Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib144","first-page":"20","article-title":"A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment","volume":"54","author":"Graffelman","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2796.2006.01657.x","article-title":"CRB\u201065 predicts death from community\u2010acquired pneumonia","volume":"260","author":"Bauer","year":"2006","journal-title":"J Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib146","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00129706","article-title":"A prediction rule for elderly primary\u2010care patients with lower respiratory tract infections","volume":"29","author":"Bont","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib147","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/archinte.168.13.1465","article-title":"Predicting death in elderly patients with community\u2010acquired pneumonia: a prospective validation study reevaluating the CRB\u201065 severity assessment tool","volume":"168","author":"Bont","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib148","series-title":"Lower respiratory tract infections in the elderly; prognostic studies in primary care","author":"Bont","year":"2008"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib149","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/fampra\/cmi020","article-title":"Prognostic factors for serious morbidity and mortality from community\u2010acquired lower respiratory tract infections among the elderly in primary care","volume":"22","author":"Hak","year":"2005","journal-title":"Fam Pract"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib150","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/archinte.161.22.2709","article-title":"Severity assessment of lower respiratory tract infection in elderly patients in primary care","volume":"161","author":"Seppa","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib151","series-title":"Over\u2010the\u2010counter (OTC) medications for acute cough in children and adults in ambulatory settings","author":"Smith","year":"2010"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib152","series-title":"Beta2\u2010agonists for acute bronchitis","author":"Smucny","year":"2010"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib153","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.04.00053604","article-title":"Efficacy of fluticasone on cough: a randomised controlled trial","volume":"25","author":"Ponsioen","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib154","series-title":"Antibiotics for acute bronchitis","author":"Smith","year":"2010"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib155","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1001\/jama.293.24.3029","article-title":"Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial","volume":"293","author":"Little","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004403.pub2","article-title":"Antibiotics for exacerbations of chronic obstructive pulmonary disease","volume":"2","author":"Ram","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002109.pub2","article-title":"Antibiotics for community acquired pneumonia in adult outpatients","volume":"2","author":"Bjerre","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib158","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.38334.591586.82","article-title":"Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non\u2010severe community acquired pneumonia: meta\u2010analysis","volume":"330","author":"Mills","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib159","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta\u2010analyses of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","article-title":"Antivirals for influenza in healthy adults: systematic review","volume":"367","author":"Jefferson","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib161","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib162","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/thx.2003.008110","article-title":"Validation of predictive rules and indices of severity for community acquired pneumonia","volume":"59","author":"Ewig","year":"2004","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib163","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thx.2008.109785","article-title":"New perspectives on community\u2010acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality","volume":"64","author":"Ewig","year":"2009","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib164","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1086\/644741","article-title":"Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia","volume":"49","author":"Aujesky","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/09031936.06.00062505","article-title":"Validation of a predictive rule for the management of community\u2010acquired pneumonia","volume":"27","author":"Capelastegui","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib166","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/thx.2005.051326","article-title":"A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia","volume":"61","author":"Buising","year":"2006","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib167","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/thx.2006.069740","article-title":"Prospective comparison of three predictive rules for assessing severity of community\u2010acquired pneumonia in Hong Kong","volume":"62","author":"Man","year":"2007","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib168","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ageing\/afj081","volume":"35","author":"Myint","year":"2006","journal-title":"Age Ageing"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib169","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/thx.2006.067371","article-title":"The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community\u2010acquired pneumonia","volume":"62","author":"Barlow","year":"2007","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/thx.2008.095562","article-title":"Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia","volume":"63","author":"Chalmers","year":"2008","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib171","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1525-1497.2006.00510.x","article-title":"Factors associated with the hospitalization of low\u2010risk patients with community\u2010acquired pneumonia in a cluster\u2010randomized trial","volume":"21","author":"Labarere","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib172","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1155\/2007\/451417","article-title":"Admission is not always necessary for patients with community\u2010acquired pneumonia in risk classes IV and V diagnosed in the emergency room","volume":"14","author":"Marrie","year":"2007","journal-title":"Can Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib173","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jemermed.2007.05.050","article-title":"Clinical judgment versus the Pneumonia Severity Index in making the admission decision","volume":"34","author":"Seymann","year":"2008","journal-title":"J Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib174","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.295.21.2503","article-title":"Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial","volume":"295","author":"Loeb","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.diagmicrobio.2008.01.014","article-title":"Comparison of usefulness of plasma procalcitonin and C\u2010reactive protein measurements for estimation of severity in adults with community\u2010acquired pneumonia","volume":"61","author":"Hirakata","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib176","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1469-0691.2009.02856.x","article-title":"Utility of C\u2010reactive protein in assessing the disease severity and complications of community\u2010acquired pneumonia","volume":"15","author":"Hohenthal","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib177","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community\u2010acquired pneumonia","volume":"64","author":"Menendez","year":"2009","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib178","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ageing\/afp164","article-title":"C\u2010reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community\u2010acquired pneumonia","volume":"38","author":"Thiem","year":"2009","journal-title":"Age Ageing"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib179","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10156-009-0722-8","article-title":"Procalcitonin and severity of community\u2010acquired pneumonia","volume":"15","author":"Okimoto","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib180","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00134-007-0895-5","article-title":"Pro\u2010atrial natriuretic peptide and pro\u2010vasopressin to predict severity and prognosis in community\u2010acquired pneumonia: results from the German competence network CAPNETZ","volume":"33","author":"Kruger","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib181","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.annemergmed.2008.12.022","article-title":"Admission D\u2010dimer can identify low\u2010risk patients with community\u2010acquired pneumonia","volume":"53","author":"Chalmers","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib182","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/dkp148","article-title":"C\u2010terminal provasopressin (copeptin) in patients with community\u2010acquired pneumonia \u2013 influence of antibiotic pre\u2010treatment: results from the German competence network CAPNETZ","volume":"64","author":"Kruger","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib183","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2796.2008.01934.x","article-title":"Use of B\u2010type natriuretic peptide in the risk stratification of community\u2010acquired pneumonia","volume":"264","author":"Christ\u2010Crain","year":"2008","journal-title":"J Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib184","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jinf.2007.07.018","article-title":"Midregional pro\u2010atrial natriuretic peptide as a prognostic marker in pneumonia","volume":"55","author":"Prat","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib185","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc4955","article-title":"Pro\u2010adrenomedullin to predict severity and outcome in community\u2010acquired pneumonia [ISRCTN04176397]","volume":"10","author":"Christ\u2010Crain","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib186","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1378\/chest.08-1981","article-title":"Midregional proadrenomedullin as a prognostic tool in community\u2010acquired pneumonia","volume":"136","author":"Huang","year":"2009","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib187","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2007.05.002","article-title":"Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells\u20101 (TREM\u20101) and other mediators of the inflammatory response","volume":"38","author":"Tejera","year":"2007","journal-title":"Cytokine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib188","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1164\/rccm.200702-307OC","article-title":"Free and total cortisol levels as predictors of severity and outcome in community\u2010acquired pneumonia","volume":"176","author":"Christ\u2010Crain","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib189","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.08-1382","article-title":"Adrenal response in severe community\u2010acquired pneumonia: impact on outcomes and disease severity","volume":"134","author":"Salluh","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.00054507","article-title":"Procalcitonin predicts patients at low risk of death from community\u2010acquired pneumonia across all CRB\u201065 classes","volume":"31","author":"Kruger","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib191","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annemergmed.2008.01.003","article-title":"Risk prediction with procalcitonin and clinical rules in community\u2010acquired pneumonia","volume":"52","author":"Huang","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib192","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/thx.2009.113795","article-title":"Validation and clinical implications of the IDSA\/ATS minor criteria for severe community\u2010acquired pneumonia","volume":"64","author":"Phua","year":"2009","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib193","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/589754","article-title":"SMART\u2010COP: a tool for predicting the need for intensive respiratory or vasopressor support in community\u2010acquired pneumonia","volume":"47","author":"Charles","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib194","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1086\/593195","article-title":"Predicting the need for mechanical ventilation and\/or inotropic support for young adults admitted to the hospital with community\u2010acquired pneumonia","volume":"47","author":"Chalmers","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib195","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1097\/CCM.0b013e3181b030d9","article-title":"Validation of the Infectious Disease Society of America\/American Thoracic Society 2007 guidelines for severe community\u2010acquired pneumonia","volume":"37","author":"Brown","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib196","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MD.0b013e3180421c16","article-title":"Community\u2010acquired pneumonia requiring admission to an intensive care unit: a descriptive study","volume":"86","author":"Marrie","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib197","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1097\/01.CCM.0000147443.38234.D2","article-title":"Validation of the 2001 American Thoracic Society criteria for severe community\u2010acquired pneumonia","volume":"32","author":"Riley","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib198","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1097\/CCM.0b013e3181b02dbb","article-title":"Association between timing of intensive care unit admission and outcomes for emergency department patients with community\u2010acquired pneumonia","volume":"37","author":"Renaud","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib199","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1183\/09031936.00003608","article-title":"Usefulness of consecutive C\u2010reactive protein measurements in follow\u2010up of severe community\u2010acquired pneumonia","volume":"32","author":"Bruns","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcrc.2006.06.009","article-title":"Early evolution of arterial oxygenation in severe community\u2010acquired pneumonia: a prospective observational study","volume":"22","author":"Wu","year":"2007","journal-title":"J Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib201","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinids\/11.4.586","article-title":"Community\u2010acquired pneumonia requiring hospitalization: 5\u2010year prospective study","volume":"11","author":"Marrie","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1128\/JCM.26.5.846-849.1988","article-title":"Sputum gram stain assessment in community\u2010acquired bacteremic pneumonia","volume":"26","author":"Gleckman","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2006.12.034","article-title":"Selective use of blood cultures in emergency department pneumonia patients","volume":"33","author":"Benenson","year":"2007","journal-title":"J Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib204","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jhm.382","article-title":"Blood cultures for community\u2010acquired pneumonia: are they worthy of two quality measures? A systematic review","volume":"4","author":"Afshar","year":"2009","journal-title":"J Hosp Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-2005-925528","article-title":"Staphylococcus aureus pneumonia: emergence of MRSA in the community","volume":"26","author":"Bradley","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib206","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/cc5917","article-title":"Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home\u2010acquired pneumonia","volume":"11","author":"El Solh","year":"2007","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib207","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/02813430410006468","article-title":"Sputum specimens can be obtained from patients with community\u2010acquired pneumonia in primary care","volume":"22","author":"Lagerstrom","year":"2004","journal-title":"Scand J Prim Health Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib208","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/archinte.164.16.1807","article-title":"Assessment of the usefulness of sputum culture for diagnosis of community\u2010acquired pneumonia using the PORT predictive scoring system","volume":"164","author":"Garcia\u2010Vazquez","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib209","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10096-005-1316-8","article-title":"Value of intensive diagnostic microbiological investigation in low\u2010 and high\u2010risk patients with community\u2010acquired pneumonia","volume":"24","author":"van der Eerden","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/421497","article-title":"Diagnostic value of microscopic examination of Gram\u2010stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia","volume":"39","author":"Musher","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib211","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S1806-37132008000300005","article-title":"Sputum examination in the clinical management of community\u2010acquired pneumonia","volume":"34","author":"Signori","year":"2008","journal-title":"J Bras Pneumol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jinf.2009.05.011","article-title":"A prospective study of the diagnostic utility of sputum Gram stain in pneumonia","volume":"59","author":"Anevlavis","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib213","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10096-003-0970-y","article-title":"Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients","volume":"22","author":"Uffredi","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib214","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/00365540510027174","article-title":"Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community\u2010acquired pneumonia","volume":"37","author":"Ortega","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/345852","article-title":"Evaluation of the immunochromatographic Binax NOW assay for detection ofStreptococcus pneumoniae urinary antigen in a prospective study of community\u2010acquired pneumonia in Spain","volume":"36","author":"Gutierrez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib216","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1378\/chest.123.5.1495","article-title":"Susceptibility testing ofPseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis","volume":"123","author":"Smith","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib217","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.03.00058802","article-title":"Rapid urinary antigen test for diagnosis of pneumococcal community\u2010acquired pneumonia in adults","volume":"21","author":"Marcos","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib218","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/380639","article-title":"Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia","volume":"38","author":"Roson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib219","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10156-004-0351-1","article-title":"A 3\u2010year prospective study of a urinary antigen\u2010detection test forStreptococcus pneumoniae in community\u2010acquired pneumonia: utility and clinical impact on the reported etiology","volume":"10","author":"Ishida","year":"2004","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib220","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/JCM.42.8.3620-3625.2004","article-title":"Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community\u2010acquired pneumonia","volume":"42","author":"Stralin","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib221","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1469-0691.2006.01484.x","article-title":"Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia","volume":"12","author":"Andreo","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib222","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7883\/yoken.JJID.2006.388","article-title":"Validation of urinary antigen test forStreptococcus pneumoniae in patients with pneumococcal pneumonia","volume":"59","author":"Ercis","year":"2006","journal-title":"Jpn J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib223","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10096-006-0113-3","article-title":"Analysis of factors that contribute to treatment failure in patients with community\u2010acquired pneumonia","volume":"25","author":"Genne","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib224","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00134-006-0329-9","article-title":"Evaluation of the Binax NOWStreptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia","volume":"32","author":"Lasocki","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib225","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JCM.43.10.4972-4976.2005","article-title":"Diagnosis of invasive pneumococcal infection by serotype\u2010specific urinary antigen detection","volume":"43","author":"Leeming","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib226","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000092547","article-title":"Evaluating the use of aStreptococcus pneumoniae urinary antigen detection kit for the management of community\u2010acquired pneumonia in Japan","volume":"74","author":"Kobashi","year":"2007","journal-title":"Respiration"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib227","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10156-009-0672-1","article-title":"The efficacy of high\u2010dose penicillin for community\u2010acquired pneumonia diagnosed by pneumococcal urine antigen test","volume":"15","author":"Oka","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib228","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JCM.01480-08","article-title":"Diagnosis ofStreptococcus pneumoniae infections in adults with bacteremia and community\u2010acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection","volume":"47","author":"Smith","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib229","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10096-008-0606-3","article-title":"Persistence ofStreptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia","volume":"28","author":"Andreo","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib230","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijid.2004.07.013","article-title":"Antibiotic treatment and the diagnosis ofStreptococcus pneumoniae in lower respiratory tract infections in adults","volume":"9","author":"Korsgaard","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib231","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jinf.2005.09.008","article-title":"Rapid detection of pneumococcal antigen in serum samples for diagnosing pneumococcal pneumonia","volume":"53","author":"Dominguez","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib232","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1378\/chest.06-1884","article-title":"Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia","volume":"131","author":"Porcel","year":"2007","journal-title":"Chest"},{"issue":"Pt 12","key":"10.1111\/j.1469-0691.2011.03602.x_bib233","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1099\/jmm.0.45909-0","article-title":"Comparison of three Legionella urinary antigen assays during an outbreak of legionellosis in Belgium","volume":"54","author":"Dirven","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib234","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/JCM.42.1.467-468.2004","article-title":"Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine","volume":"42","author":"Guerrero","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib235","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10096-008-0697-x","article-title":"Comparison of the sensitivity of the Legionella urinary antigen EIA kits from Binax and Biotest with urine from patients with infections caused by less common serogroups and subgroups of Legionella","volume":"28","author":"Olsen","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib236","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10096-008-0559-6","article-title":"Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay","volume":"27","author":"Blanco","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib237","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/JCM.00397-09","article-title":"Evaluation of the Oxoid Xpect Legionella test kit for detection of Legionella pneumophila serogroup 1 antigen in urine","volume":"47","author":"Diederen","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib238","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/j.ijid.2009.01.004","article-title":"Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in Catalonia, Spain, 1990\u20132004","volume":"13","author":"Alvarez","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib239","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10096-005-1361-3","article-title":"Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain","volume":"24","author":"Blazquez","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib240","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1086\/586741","article-title":"Community\u2010acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia","volume":"46","author":"von","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib241","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1469-0691.2008.02674.x","article-title":"Near\u2010patient assays for diagnosis of influenza virus infection in adult patients","volume":"15","author":"Steininger","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib242","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-976489","article-title":"Respiratory syncytial virus infection in adults","volume":"28","author":"Falsey","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib243","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/JCM.43.5.2277-2285.2005","article-title":"Evaluation of 12 commercial tests and the complement fixation test forMycoplasma pneumoniae\u2010specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the \u201cgold standard\u201d","volume":"43","author":"Beersma","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib244","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/CDLI.11.5.862-867.2004","article-title":"Analysis of eight commercial enzyme immunoassay tests for detection of antibodies toMycoplasma pneumoniae in human serum","volume":"11","author":"Talkington","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib245","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1469-0691.2006.01469.x","article-title":"Evaluation of eight commercial tests forMycoplasma pneumoniae antibodies in the absence of acute infection","volume":"12","author":"Nir\u2010Paz","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib246","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1128\/JCM.41.9.4366-4371.2003","article-title":"Comparison and evaluation of real\u2010time PCR, real\u2010time nucleic acid sequence\u2010based amplification, conventional PCR, and serology for diagnosis ofMycoplasma pneumoniae","volume":"41","author":"Templeton","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"Pt 12","key":"10.1111\/j.1469-0691.2011.03602.x_bib247","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1099\/jmm.0.2008\/003814-0","article-title":"Detection ofMycoplasma pneumoniae in adult community\u2010acquired pneumonia by PCR and serology","volume":"57","author":"Martinez","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib248","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2334-9-62","article-title":"Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community\u2010acquired pneumonia (CAPNETZ)","volume":"9","author":"von","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib249","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1469-0691.2008.02075.x","article-title":"Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling","volume":"15","author":"Hvidsten","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10096-007-0410-5","article-title":"Comparison and evaluation of four commercial kits relative to an in\u2010house immunofluorescence test for detection of antibodies against Legionella pneumophila","volume":"27","author":"Elverdal","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib251","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2007.10.011","article-title":"Quantitative detection ofStreptococcus pneumoniae from sputum samples with real\u2010time quantitative polymerase chain reaction for etiologic diagnosis of community\u2010acquired pneumonia","volume":"60","author":"Johansson","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib252","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2009.03069.x","article-title":"Usefulness of real\u2010time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia","volume":"16","author":"Abdeldaim","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib253","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/JCM.01071-09","article-title":"Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community\u2010acquired pneumonia","volume":"47","author":"Peters","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib254","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1378\/chest.09-0258","article-title":"Severity of pneumococcal pneumonia associated with genomic bacterial load","volume":"136","author":"Rello","year":"2009","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib255","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.diagmicrobio.2009.03.030","article-title":"Detection ofHaemophilus influenzae in respiratory secretions from pneumonia patients by quantitative real\u2010time polymerase chain reaction","volume":"64","author":"Abdeldaim","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib256","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-0691.2009.02812.x","article-title":"Quantitative real\u2010time PCR tests for diagnostic and prognostic purposes in cases of legionellosis","volume":"16","author":"Maurin","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"Pt 3","key":"10.1111\/j.1469-0691.2011.03602.x_bib257","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/jmm.0.45888-0","article-title":"Sample type is crucial to the diagnosis ofMycoplasma pneumoniae pneumonia by PCR","volume":"54","author":"Raty","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib258","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/JCM.01196-07","article-title":"Utility of real\u2010time PCR for diagnosis of Legionnaires\u2019 disease in routine clinical practice","volume":"46","author":"Diederen","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib259","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2180-8-93","article-title":"Polymerase chain reaction is superior to serology for the diagnosis of acuteMycoplasma pneumoniae infection and reveals a high rate of persistent infection","volume":"8","author":"Nilsson","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib260","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/597775","article-title":"Comparison of laboratory diagnostic procedures for detection ofMycoplasma pneumoniae in community outbreaks","volume":"48","author":"Thurman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib261","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JCM.02187-07","article-title":"Comparison of serological and real\u2010time PCR assays to diagnose Bordetella pertussis infection in 2007","volume":"46","author":"Andre","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib262","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/513432","article-title":"Evaluation of polymerase chain reaction and culture for diagnosis of pertussis in the control of a county\u2010wide outbreak focused among adolescents and adults","volume":"44","author":"Sotir","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib263","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/JCM.02436-06","article-title":"Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead\u2010based assay","volume":"45","author":"Mahony","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib264","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/JCM.00848-07","article-title":"Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real\u2010time PCR in samples from patients with respiratory symptoms","volume":"45","author":"van de Pol","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcv.2009.06.005","article-title":"Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak","volume":"45","author":"Ginocchio","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib266","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1532-5415.2008.02153.x","article-title":"Respiratory syncytial virus outbreak in a long\u2010term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real\u2010time detection methods","volume":"57","author":"Caram","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib267","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MD.0b013e318178923a","article-title":"Treatment and outcomes for patients with bacteremic pneumococcal pneumonia","volume":"87","author":"Berjohn","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib268","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.annemergmed.2008.07.017","article-title":"Delayed administration of antibiotics and mortality in patients with community\u2010acquired pneumonia 89","volume":"53","author":"Cheng","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib269","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.annemergmed.2006.11.008","article-title":"Identification of 90% of patients ultimately diagnosed with community\u2010acquired pneumonia within four hours of emergency department arrival may not be feasible","volume":"49","author":"Fee","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib270","first-page":"137","article-title":"Reporting hospitals\u2019 antibiotic timing in pneumonia: adverse consequences for patients?","volume":"15","author":"Friedberg","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib271","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1378\/chest.07-0164","article-title":"Misdiagnosis of community\u2010acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4\u2010h antibiotic administration rule","volume":"131","author":"Kanwar","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib272","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jemermed.2009.06.127","article-title":"The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine","volume":"37","author":"Pines","year":"2009","journal-title":"J Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib273","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10096-009-0724-6","article-title":"Time for first antibiotic dose is not predictive for the early clinical failure of moderate\u2010severe community\u2010acquired pneumonia","volume":"28","author":"Bruns","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib274","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1179\/joc.2007.19.5.536","article-title":"A case series of macrolide treatment failures in community acquired pneumonia","volume":"19","author":"Iannini","year":"2007","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.03.008","article-title":"A review of clinical failures associated with macrolide\u2010resistantStreptococcus pneumoniae","volume":"24","author":"Rzeszutek","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib276","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/AAC.00006-07","article-title":"Comparison of beta\u2010lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community\u2010acquired pneumonia","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib277","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.06-1426","article-title":"Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones","volume":"131","author":"Metersky","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib278","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/dkp088","article-title":"Impact of intravenous {beta}\u2010lactam\/macrolide versus {beta}\u2010lactam monotherapy on mortality in hospitalized patients with community\u2010acquired pneumonia","volume":"63","author":"Tessmer","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib279","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.00031007","article-title":"The need for macrolides in hospitalised community\u2010acquired pneumonia: propensity analysis","volume":"30","author":"Paul","year":"2007","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1111\/j.1469-0691.2011.03602.x_bib280","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.ijantimicag.2007.07.038","article-title":"The development of pharmacokinetically enhanced amoxicillin\/clavulanate for the management of respiratory tract infections in adults","volume":"30","author":"File","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib281","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-8579(02)00126-7","article-title":"The efficacy and safety of oral pharmacokinetically enhanced amoxycillin\u2010clavulanate 2000\/125 mg, twice daily, versus oral amoxycillin\u2010clavulanate 1000\/125 mg, three times daily, for the treatment of bacterial community\u2010acquired pneumonia in adults","volume":"20","author":"Petitpretz","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib282","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jac\/dki480","article-title":"Efficacy and safety of twice\u2010daily pharmacokinetically enhanced amoxicillin\/clavulanate (2000\/125 mg) in the treatment of adults with community\u2010acquired pneumonia in a country with a high prevalence of penicillin\u2010resistantStreptococcus pneumoniae","volume":"57","author":"Siquier","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1111\/j.1469-0691.2011.03602.x_bib283","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1179\/joc.2008.20.Supplement-1.28","article-title":"Tigecycline versus levofloxacin for the treatment of community\u2010acquired pneumonia: European experience","volume":"20","author":"Dartois","year":"2008","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib284","first-page":"321","article-title":"An open\u2010label, randomized comparison of levofloxacin and amoxicillin\/clavulanate plus clarithromycin for the treatment of hospitalized patients with community\u2010acquired pneumonia","volume":"30","author":"Lin","year":"2007","journal-title":"Chang Gung Med J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10096-005-1347-1","article-title":"Moxifloxacin monotherapy compared to amoxicillin\u2010clavulanate plus roxithromycin for nonsevere community\u2010acquired pneumonia in adults with risk factors","volume":"24","author":"Portier","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib286","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijantimicag.2004.07.013","article-title":"Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community\u2010acquired pneumonia requiring hospitalization","volume":"25","author":"Querol\u2010Ribelles","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib287","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1345\/aph.1C167","article-title":"Fluoroquinolone treatment of community\u2010acquired pneumonia: a meta\u2010analysis","volume":"36","author":"Salkind","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib288","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1185\/030079908X273408","article-title":"A comparison of levofloxacin and moxifloxacin use in hospitalized community\u2010acquired pneumonia (CAP) patients in the US: focus on length of stay","volume":"24","author":"Schein","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib289","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2008.04.009","article-title":"Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community\u2010acquired pneumonia 509","volume":"61","author":"Tanaseanu","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib290","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2466-9-44","article-title":"Efficacy and safety of tigecycline versus levofloxacin for community\u2010acquired pneumonia","volume":"9","author":"Tanaseanu","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib291","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.03.00045202","article-title":"Effectiveness of oral moxifloxacin in standard first\u2010line therapy in community\u2010acquired pneumonia","volume":"21","author":"Torres","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib292","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1503\/cmaj.080358","article-title":"Respiratory fluoroquinolones for the treatment of community\u2010acquired pneumonia: a meta\u2010analysis of randomized controlled trials","volume":"179","author":"Vardakas","year":"2008","journal-title":"CMAJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib293","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00002018-200932050-00001","article-title":"Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes","volume":"32","author":"Van","year":"2009","journal-title":"Drug Saf"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib294","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diagmicrobio.2008.09.001","article-title":"Safety and efficacy of intravenous tigecycline in treatment of community\u2010acquired pneumonia: results from a double\u2010blind randomized phase 3 comparison study with levofloxacin","volume":"63","author":"Bergallo","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"10.1111\/j.1469-0691.2011.03602.x_bib295","first-page":"ii59","article-title":"Ertapenem versus ceftriaxone for the treatment of community\u2010acquired pneumonia in adults: combined analysis of two multicentre randomized, double\u2010blind studies","volume":"53","author":"Ortiz\u2010Ruiz","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib296","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0149-2918(02)80078-9","article-title":"A prospective, randomized, double\u2010blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community\u2010acquired pneumonia","volume":"24","author":"Vetter","year":"2002","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib297","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10096-006-0193-0","article-title":"Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled\u2010care facilities or in hospitals outside the intensive care unit","volume":"25","author":"Yakovlev","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib298","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1183\/09031936.00092507","article-title":"Outcome of community\u2010acquired pneumonia: influence of age, residence status and antimicrobial treatment","volume":"32","author":"Kothe","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib299","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1469-0691.2009.02843.x","article-title":"Clinical response to ertapenem in severe community\u2010acquired pneumonia: a retrospective series in an elderly population","volume":"15","author":"Murcia","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib300","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1532-5415.2007.01152.x","article-title":"Once\u2010daily cefepime versus ceftriaxone for nursing home\u2010acquired pneumonia","volume":"55","author":"Paladino","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib301","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1183\/09031936.00091809","article-title":"Community\u2010acquired pneumonia through Enterobacteriaceae andPseudomonas aeruginosa: Diagnosis, incidence and predictors","volume":"35","author":"von","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib302","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1592\/phco.23.10.1167.32764","article-title":"Impact of atypical coverage for patients with community\u2010acquired pneumonia managed on the medical ward: results from the United States Community\u2010Acquired Pneumonia Project","volume":"23","author":"Frei","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib303","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1440-1843.2009.01637.x","article-title":"Role of \u2018atypical pathogens\u2019 among adult hospitalized patients with community\u2010acquired pneumonia","volume":"14","author":"Lui","year":"2009","journal-title":"Respirology"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib304","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004418.pub2","article-title":"Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults","volume":"2","author":"Shefet","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10096-005-1295-9","article-title":"Lower mortality among patients with community\u2010acquired pneumonia treated with a macrolide plus a beta\u2010lactam agent versus a beta\u2010lactam agent alone","volume":"24","author":"Garcia","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 4","key":"10.1111\/j.1469-0691.2011.03602.x_bib306","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1086\/382689","article-title":"Monotherapy versus dual therapy for community\u2010acquired pneumonia in hospitalized patients","volume":"38","author":"Martinez","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib307","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1155\/2004\/461392","article-title":"Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremicStreptococcus pneumoniae pneumonia in adults","volume":"11","author":"Weiss","year":"2004","journal-title":"Can Respir J"},{"issue":"Suppl 2","key":"10.1111\/j.1469-0691.2011.03602.x_bib308","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1120009X.2004.11782368","article-title":"Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients","volume":"16","author":"Alvarez","year":"2004","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10096-003-1060-x","article-title":"Full\u2010course oral levofloxacin for treatment of hospitalized patients with community\u2010acquired pneumonia","volume":"23","author":"Erard","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jemermed.2004.02.023","article-title":"Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community\u2010acquired pneumonia in patients requiring initial i.v. therapy","volume":"27","author":"Katz","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib311","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0954-6111(03)00166-5","article-title":"Sequential IV\/PO moxifloxacin treatment of patients with severe community\u2010acquired pneumonia","volume":"97","author":"Lode","year":"2003","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib312","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community\u2010acquired pneumonia and shock","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib313","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/587519","article-title":"Moxifloxacin monotherapy is effective in hospitalized patients with community\u2010acquired pneumonia: the MOTIV study \u2013 a randomized clinical trial","volume":"46","author":"Torres","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib314","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1183\/09031936.04.00143303","article-title":"Cost\u2010effectiveness of full\u2010course oral levofloxacin in severe community\u2010acquired pneumonia","volume":"24","author":"Wasserfallen","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib315","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1179\/joc.2002.14.6.609","article-title":"Carbapenems in the treatment of severe community\u2010acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy","volume":"14","author":"Romanelli","year":"2002","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib316","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/381886","article-title":"Drug\u2010resistant pneumococcal pneumonia: clinical relevance and related factors","volume":"38","author":"Aspa","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib317","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jinf.2004.08.016","article-title":"Community\u2010acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome","volume":"51","author":"Bonnard","year":"2005","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib318","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkh338","article-title":"Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?","volume":"54","author":"Falco","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib319","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000114817.58194.BF","article-title":"Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality","volume":"32","author":"Lujan","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib320","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/379329","article-title":"Azithromycin in the treatment of Legionella pneumonia requiring hospitalization","volume":"37","author":"Plouffe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib321","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of Legionnaires disease","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib322","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1378\/chest.125.6.2135","article-title":"Levofloxacin efficacy in the treatment of community\u2010acquired legionellosis","volume":"125","author":"Yu","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib323","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjmed.2008.05.010","article-title":"Declining length of hospital stay for pneumonia and postdischarge outcomes","volume":"121","author":"Capelastegui","year":"2008","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib324","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1086\/526526","article-title":"Causes and risk factors for rehospitalization of patients hospitalized with community\u2010acquired pneumonia","volume":"46","author":"Jasti","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib325","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","article-title":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis","volume":"177","author":"Yende","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib326","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator\u2010associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib327","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community\u2010acquired pneumonia: a randomized trial","volume":"174","author":"Christ\u2010Crain","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib328","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","article-title":"Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission \u2013 a randomized trial","volume":"15","author":"Kristoffersen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib329","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin\u2010based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib330","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib331","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","article-title":"Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial","volume":"177","author":"Nobre","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib332","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2165\/0003495-200868170-00005","article-title":"Early switch to oral treatment in patients with moderate to severe community\u2010acquired pneumonia: a meta\u2010analysis","volume":"68","author":"Athanassa","year":"2008","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib333","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1440-1843.2006.00931.x","article-title":"Early switch to oral antibiotics and early discharge guidelines in the management of community\u2010acquired pneumonia","volume":"12","author":"Lee","year":"2007","journal-title":"Respirology"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib334","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjmed.2003.11.013","article-title":"Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community\u2010acquired pneumonia: a retrospective study and meta\u2010analysis","volume":"116","author":"Marras","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib335","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0149-2918(04)90028-8","article-title":"Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community\u2010acquired pneumonia","volume":"26","author":"van der Eerden","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib336","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2169\/internalmedicine.47.1343","article-title":"Implication of clinical pathway care for community\u2010acquired pneumonia in a community hospital: early switch from an intravenous beta\u2010lactam plus a macrolide to an oral respiratory fluoroquinolone","volume":"47","author":"Shindo","year":"2008","journal-title":"Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib337","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.amjmed.2005.09.012","article-title":"In\u2010hospital observation after antibiotic switch in pneumonia: a national evaluation","volume":"119","author":"Nathan","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib338","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","article-title":"Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial","volume":"333","author":"Oosterheert","year":"2006","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib339","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1378\/chest.124.3.883","article-title":"Early mobilization of patients hospitalized with community\u2010acquired pneumonia","volume":"124","author":"Mundy","year":"2003","journal-title":"Chest"},{"issue":"5 Pt 1","key":"10.1111\/j.1469-0691.2011.03602.x_bib340","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1164\/ajrccm.160.5.9903015","article-title":"Acute respiratory failure in patients with severe community\u2010acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation","volume":"160","author":"Confalonieri","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib341","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1164\/rccm.200301-072OC","article-title":"Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial","volume":"168","author":"Ferrer","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib342","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.CCM.0000251821.44259.F3","article-title":"A multiple\u2010center survey on the use in clinical practice of noninvasive ventilation as a first\u2010line intervention for acute respiratory distress syndrome","volume":"35","author":"Antonelli","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib343","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1399-6576.2009.02034.x","article-title":"Non\u2010invasive ventilation in do\u2010not\u2010intubate patients: five\u2010year follow\u2010up on a two\u2010year prospective, consecutive cohort study","volume":"53","author":"Bulow","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib344","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community\u2010acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib345","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1345\/aph.1H660","article-title":"Corticosteroid treatment of severe community\u2010acquired pneumonia","volume":"41","author":"Gorman","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib346","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc6922","article-title":"The role of corticosteroids in severe community\u2010acquired pneumonia: a systematic review","volume":"12","author":"Salluh","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib347","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/dkn283","article-title":"Adjunctive therapies for community\u2010acquired pneumonia: a systematic review","volume":"62","author":"Siempos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib348","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1445-5994.1997.tb00963.x","article-title":"The value of the lipid\u2010laden macrophage index in the assessment of aspiration pneumonia","volume":"27","author":"Adams","year":"1997","journal-title":"Aust N Z J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib349","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1532-5415.2005.00524.x","article-title":"Occurrence and treatment of suspected pneumonia in long\u2010term care residents dying with advanced dementia","volume":"54","author":"Chen","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib350","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.yebeh.2004.03.009","article-title":"Risk of aspiration pneumonia after an epileptic seizure: a retrospective analysis of 1634 adult patients","volume":"5","author":"DeToledo","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib351","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.127.4.1276","article-title":"Reappraisal of clindamycin IV monotherapy for treatment of mild\u2010to\u2010moderate aspiration pneumonia in elderly patients","volume":"127","author":"Kadowaki","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib352","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01690548","article-title":"Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures","volume":"19","author":"Mier","year":"1993","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib353","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1601-5215.2002.51004.x","article-title":"Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management","volume":"51","author":"Mylotte","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib354","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1532-5415.2005.00608.x","article-title":"Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility","volume":"54","author":"Reza","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib355","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1532-5415.2008.01597.x","article-title":"High incidence of aspiration pneumonia in community\u2010 and hospital\u2010acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan","volume":"56","author":"Teramoto","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib356","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1469-0691.2004.00774.x","article-title":"Ampicillin + sulbactam vs clindamycin +\/\u2212 cephalosporin for the treatment of aspiration pneumonia and primary lung abscess","volume":"10","author":"Allewelt","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib357","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.1975.03260220039016","article-title":"Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin","volume":"234","author":"Bartlett","year":"1975","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib358","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10096-003-0898-2","article-title":"Efficacy and safety of sequential amoxicillin\u2010clavulanate in the treatment of anaerobic lung infections","volume":"22","author":"Fernandez\u2010Sabe","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib359","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/archinte.1990.00390230077010","article-title":"Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin\u2010resistant Bacteroides melaninogenicus","volume":"150","author":"Gudiol","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib360","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/archinte.1981.00340120032009","article-title":"Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy","volume":"141","author":"Perlino","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib361","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s15010-007-7043-6","article-title":"Moxifloxacin vs ampicillin\/sulbactam in aspiration pneumonia and primary lung abscess","volume":"36","author":"Ott","year":"2008","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib362","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0929-6646(09)60055-3","article-title":"Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community\u2010acquired pneumonia","volume":"108","author":"Chen","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib363","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2007.086785","article-title":"Markers of treatment failure in hospitalised community acquired pneumonia","volume":"63","author":"Menendez","year":"2008","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib364","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C\u2010reactive protein is an independent predictor of severity in community\u2010acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib365","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/cc6105","article-title":"Usefulness of C\u2010reactive protein in monitoring the severe community\u2010acquired pneumonia clinical course","volume":"11","author":"Coelho","year":"2007","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib366","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10096-002-0872-4","article-title":"Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease","volume":"22","author":"Lieberman","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib367","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.rmed.2004.10.020","article-title":"Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease","volume":"99","author":"Allegra","year":"2005","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib368","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.2005.056374","article-title":"Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease","volume":"62","author":"Soler","year":"2007","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib369","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.rmed.2008.10.012","article-title":"Relation of sputum colour to bacterial load in acute exacerbations of COPD","volume":"103","author":"Brusse\u2010Keizer","year":"2009","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jinf.2007.05.181","article-title":"Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs","volume":"55","author":"Burley","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib371","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin\u2010guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib372","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/thorax.58.1.37","article-title":"Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case\u2010control study","volume":"58","author":"Rohde","year":"2003","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib373","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0732-8893(02)00421-2","article-title":"Serological evidence ofMycoplasma pneumoniae infection in acute exacerbation of COPD","volume":"44","author":"Lieberman","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib374","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0954-6111(03)00026-X","article-title":"Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1\u2010year prospective study","volume":"97","author":"Groenewegen","year":"2003","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib375","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.rmed.2004.09.011","article-title":"Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong","volume":"99","author":"Ko","year":"2005","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib376","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.165.8.891","article-title":"Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease","volume":"165","author":"Rosell","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib377","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2006.00999.x","article-title":"Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis onKlebsiella pneumoniae andPseudomonas aeruginosa","volume":"12","author":"Lin","year":"2007","journal-title":"Respirology"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib378","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s15010-008-8125-9","article-title":"Mortality of COPD patients infected with multi\u2010resistantPseudomonas aeruginosa: a case and control study","volume":"37","author":"Montero","year":"2009","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib379","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s15010-007-6078-z","article-title":"A prediction model for bacterial etiology in acute exacerbations of COPD","volume":"35","author":"Lode","year":"2007","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib380","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1183\/09031936.00003309","article-title":"Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study","volume":"34","author":"Garcia\u2010Vidal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib381","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/030079907X159515","article-title":"Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity","volume":"23","author":"Kahn","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib382","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/rccm.200412-1747OC","article-title":"Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response","volume":"172","author":"Murphy","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib383","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/rccm.200403-354OC","article-title":"Persistent colonization byHaemophilus influenzae in chronic obstructive pulmonary disease","volume":"170","author":"Murphy","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib384","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib385","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","article-title":"Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease","volume":"167","author":"Wilkinson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib386","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.200703-417OC","article-title":"Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease","volume":"176","author":"Sethi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib387","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.200308-1181OC","article-title":"Strain\u2010specific immune response toHaemophilus influenzae in chronic obstructive pulmonary disease","volume":"169","author":"Sethi","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib388","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1183\/09031936.04.00049104","article-title":"Sputum versus bronchoscopy for diagnosis ofPseudomonas aeruginosa biofilms in cystic fibrosis","volume":"24","author":"Aaron","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib389","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/rmed.2003.1435","article-title":"Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone\/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis","volume":"97","author":"Wilson","year":"2003","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib390","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1183\/09031936.05.00106404","article-title":"Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg","volume":"25","author":"Martinez","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib391","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1378\/chest.07-0149","article-title":"Comparison of first\u2010line with second\u2010line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials","volume":"132","author":"Dimopoulos","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib392","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/01.CCM.0000178185.50422.DB","article-title":"Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease","volume":"33","author":"Ferrer","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib393","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations ofPseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib394","article-title":"Prolonged antibiotics for purulent bronchiectasis","volume":"4","author":"Evans","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib395","first-page":"81","article-title":"Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study","volume":"74","author":"Cogo","year":"2003","journal-title":"Acta Biomed Ateneo Parmense"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib396","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001958","article-title":"Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis","volume":"3","author":"Foxwell","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib397","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1378\/chest.126.5.1645","article-title":"Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review","volume":"126","author":"Steurer\u2010Stey","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib398","first-page":"57","article-title":"Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double\u2010blind clinical trial","volume":"54","author":"Tricarico","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib399","article-title":"Prophylactic antibiotic therapy for chronic bronchitis","volume":"1","author":"Black","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib400","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001726.pub2","article-title":"Antibiotics for acute bronchitis","volume":"4","author":"Smucny","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib401","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib402","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long\u2010term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations 86","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib403","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non\u2010cystic fibrosis patients with bronchiectasis and chronic bronchial infection withPseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"2 Pt 1","key":"10.1111\/j.1469-0691.2011.03602.x_bib404","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputumPseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib405","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease\u2010modifying effects of twice\u2010weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib406","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long\u2010term low\u2010dose azithromycin in patients with non\u2010CF bronchiectasis 232","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib407","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079905X46214","article-title":"Risk of pneumonia and other complications of influenza\u2010like illness in patients treated with oseltamivir","volume":"21","author":"Nordstrom","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib408","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287.pub2","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"3","author":"Poole","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib409","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000980.pub2","article-title":"Vitamin C for preventing and treating the common cold","volume":"4","author":"Douglas","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib410","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-137-12-200212170-00006","article-title":"Treatment of the common cold with unrefined echinacea. A randomized, double\u2010blind, placebo\u2010controlled trial","volume":"137","author":"Barrett","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib411","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/acm.2006.12.153","article-title":"Efficacy of COLD\u2010fX in the prevention of respiratory symptoms in community\u2010dwelling adults: a randomized, double\u2010blinded, placebo controlled trial","volume":"12","author":"McElhaney","year":"2006","journal-title":"J Altern Complement Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib412","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1532-5415.2008.01926.x","article-title":"A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: effect estimates and methodological quality of randomized controlled trials","volume":"56","author":"Sjogren","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib413","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/154405910808700418","article-title":"Oral health and mortality risk from pneumonia in the elderly","volume":"87","author":"Awano","year":"2008","journal-title":"J Dent Res"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib414","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1532-5415.2008.01825.x","article-title":"Modification of the risk of mortality from pneumonia with oral hygiene care","volume":"56","author":"Bassim","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib415","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long\u2010term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta\u2010analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib416","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1183\/09031936.00095807","article-title":"New evidence of risk factors for community\u2010acquired pneumonia: a population\u2010based study","volume":"31","author":"Almirall","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib417","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib418","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2008.717","article-title":"Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta\u2010analysis","volume":"300","author":"Drummond","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib419","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(09)61250-2","article-title":"Budesonide and the risk of pneumonia: a meta\u2010analysis of individual patient data","volume":"374","author":"Sin","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib420","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1183\/09031936.00162006","article-title":"Impact of statins and angiotensin\u2010converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia","volume":"31","author":"Mortensen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib421","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2008.06.030","article-title":"Prior statin use is associated with improved outcomes in community\u2010acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib422","doi-asserted-by":"crossref","first-page":"b2137","DOI":"10.1136\/bmj.b2137","article-title":"Statin use and risk of community acquired pneumonia in older people: population based case\u2010control study","volume":"338","author":"Dublin","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib423","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1592\/phco.27.3.325","article-title":"Statins and the risk of pneumonia: a population\u2010based, nested case\u2010control study","volume":"27","author":"Schlienger","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib424","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.168.19.2081","article-title":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population\u2010based cohort study of 29,900 patients","volume":"168","author":"Thomsen","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib425","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","article-title":"Statins for the prevention and treatment of infections: a systematic review and meta\u2010analysis","volume":"169","author":"Tleyjeh","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib426","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/archinte.165.3.274","article-title":"Clinical effectiveness of influenza vaccination in persons younger than 65 years with high\u2010risk medical conditions: the PRISMA study","volume":"165","author":"Hak","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib427","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/aje\/kwg027","article-title":"Conventional influenza vaccination is not associated with complications in working\u2010age patients with asthma or chronic obstructive pulmonary disease","volume":"157","author":"Hak","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib428","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/thx.2008.106286","article-title":"Influenza but not pneumococcal vaccination protects against all\u2010cause mortality in patients with COPD","volume":"64","author":"Schembri","year":"2009","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib429","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.00135306","article-title":"Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area","volume":"30","author":"Ortqvist","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib430","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib431","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.200802-282OC","article-title":"Mortality reduction with influenza vaccine in patients with pneumonia outside \u201cflu\u201d season: pleiotropic benefits or residual confounding?","volume":"178","author":"Eurich","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib432","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(08)61160-5","article-title":"Influenza vaccination and risk of community\u2010acquired pneumonia in immunocompetent elderly people: a population\u2010based, nested case\u2010control study 181","volume":"372","author":"Jackson","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib433","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib434","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double\u2010blind placebo\u2010controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"issue":"RR\u20106","key":"10.1111\/j.1469-0691.2011.03602.x_bib435","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007","volume":"56","author":"Fiore","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib436","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.2009.265","article-title":"Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel","volume":"301","author":"Wang","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib437","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib438","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpedi.162.12.1113","article-title":"Influenza vaccination among college and university students: impact on influenzalike illness, health care use, and impaired school performance","volume":"162","author":"Nichol","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib439","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub2","article-title":"Vaccines for preventing influenza in healthy adults","volume":"3","author":"Demicheli","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib440","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005187.pub2","article-title":"Influenza vaccination for healthcare workers who work with the elderly","volume":"3","author":"Thomas","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib441","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005187.pub3","article-title":"Influenza vaccination for healthcare workers who work with the elderly","volume":"2","author":"Thomas","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib442","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/09031936.05.00073204","article-title":"Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology","volume":"25","author":"van Kessel","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib443","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.vaccine.2006.09.018","article-title":"Non\u2010response to specific serotypes likely cause for failure to 23\u2010valent pneumococcal polysaccharide vaccine in the elderly","volume":"25","author":"Ortqvist","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib444","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.vaccine.2004.01.029","article-title":"Review of pneumococcal conjugate vaccine in adults: implications on clinical development","volume":"22","author":"Abraham\u2010Van Parijs","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib445","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein\u2010conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib446","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib447","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug\u2010resistantStreptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib448","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2010polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib449","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time\u2010series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib450","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults 211","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib451","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/B:EJEP.0000024701.94769.98","article-title":"The 23\u2010valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta\u2010analyses","volume":"19","author":"Melegaro","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib452","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"4","author":"Dear","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib453","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2003.08.050","article-title":"The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials","volume":"22","author":"Conaty","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib454","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000422.pub2","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib455","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/thx.2005.043323","article-title":"Clinical efficacy of anti\u2010pneumococcal vaccination in patients with COPD","volume":"61","author":"Alfageme","year":"2006","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib456","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib457","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1183\/09031936.04.00063504","article-title":"Additive preventive effect of influenza and pneumococcal vaccines in elderly persons","volume":"23","author":"Christenson","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib458","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23\u2010valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN\u201065 study","volume":"43","author":"Vila\u2010Corcoles","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib459","doi-asserted-by":"crossref","first-page":"c1004","DOI":"10.1136\/bmj.c1004","article-title":"Efficacy of 23\u2010valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial","volume":"340","author":"Maruyama","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib460","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-422X-5-52","article-title":"Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity","volume":"5","author":"Christenson","year":"2008","journal-title":"Virol J"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib461","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.vaccine.2008.02.021","article-title":"Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN\u201065 study","volume":"26","author":"Ochoa\u2010Gondar","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib462","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-007-0118-3","article-title":"Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma","volume":"22","author":"Lee","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib463","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1016\/j.vaccine.2007.03.015","article-title":"Prevention of community\u2010acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated","volume":"25","author":"Skull","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib464","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2008.06.073","article-title":"Effects of a large\u2010scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden","volume":"26","author":"Spindler","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-8-53","article-title":"The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003\/2004","volume":"8","author":"Mooney","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib466","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/501354","article-title":"Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community\u2010acquired pneumonia","volume":"42","author":"Fisman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib467","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10096-006-0161-8","article-title":"Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community\u2010acquired pneumococcal pneumonia","volume":"25","author":"Mykietiuk","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib468","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/B:EJEP.0000024752.48929.bd","article-title":"The 23\u2010valent pneumococcal polysaccharide vaccine. Part II. A cost\u2010effectiveness analysis for invasive disease in the elderly in England and Wales","volume":"19","author":"Melegaro","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib469","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ije\/dyh341","article-title":"An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting","volume":"34","author":"Mangtani","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib470","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.vaccine.2004.08.051","article-title":"Pneumococcal pneumonia in the UK \u2013 how herd immunity affects the cost\u2010effectiveness of 7\u2010valent pneumococcal conjugate vaccine (PCV)","volume":"23","author":"McIntosh","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib471","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.vaccine.2005.02.017","article-title":"Safety of varying dosages of 7\u2010valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23\u2010valent pneumococcal polysaccharide vaccine","volume":"23","author":"Jackson","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib472","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0264-410X(03)00521-8","article-title":"Revaccination with the 23\u2010valent pneumococcal polysaccharide vaccine in middle\u2010aged and elderly persons previously treated for pneumonia","volume":"22","author":"Torling","year":"2003","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib473","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10790268.2008.11753981","article-title":"Revaccination of adults with spinal cord injury using the 23\u2010valent pneumococcal polysaccharide vaccine","volume":"31","author":"Waites","year":"2008","journal-title":"J Spinal Cord Med"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib474","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.292.19.2366","article-title":"Inpatient computer\u2010based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial","volume":"292","author":"Dexter","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib475","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003941.pub2","article-title":"Patient reminder and patient recall systems to improve immunization rates","volume":"3","author":"Jacobson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib476","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jamda.2005.01.001","article-title":"Project protect: pneumococcal vaccination in Washington State nursing homes","volume":"6","author":"deHart","year":"2005","journal-title":"J Am Med Dir Assoc"},{"key":"10.1111\/j.1469-0691.2011.03602.x_bib477","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2105\/AJPH.2006.099440","article-title":"Performance measures, vaccinations, and pneumonia rates among high\u2010risk patients in Veterans Administration health care","volume":"97","author":"Jha","year":"2007","journal-title":"Am J Public Health"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14614038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14614038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T23:23:26Z","timestamp":1712964206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14614038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":477,"alternative-id":["S1198743X14614038"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03602.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}